Rheumatologic manifestations of sarcoidosis

Current Opinion in Rheumatology

Volumn 16, Issue 1, 2004, Pages 51-55

  Abril, Andy ^a   Cohen, Marc D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Arthritis; Granulomas; Sarcoidosis

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PREDNISONE; THALIDOMIDE;

ARTHRITIS; AUTOIMMUNE DISEASE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG DISEASE; MEDICAL LITERATURE; MUSCULOSKELETAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RHEUMATOLOGY; SARCOIDOSIS; SIDE EFFECT;

GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PEPTIDYL-DIPEPTIDASE A; PREDNISONE; RHEUMATIC DISEASES; SARCOIDOSIS;

EID: 0346155811     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200401000-00010     Document Type: Review

References (45)

1. Kelley WN: Textbook of Rheumatology, edn 4. Philadelphia: WB Saunders Co.; 1993.
2. Agostini C, Costabel U, Semenzato G: Sarcoidosis news: immunologic frontiers for new immunosuppressive strategies. Clin Immunol Immunopathol 1998, 88:199-204.
3. Visser H, Vos K, Zanelli E, et al.: Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis 2002, 61:499-504.
4. Petterson T: Rheumatic features of sarcoidosis. Curr Opin Rheumatol 1997, 9:62-67.
5. Roman J, Galis ZS: Sarcoidosis: a mysterious tale of inflammation, tissue remodeling, and matrix metalloproteinases. Human Pathol 2002, 33:1155-1157.
6. Jones RE, Chatham WW: Update on sarcoidosis. Curr Opin Rheumatol 1999, 11:83-87.
7. Moller DR: Treatment of sarcoidosis-from a basic science point of view. J Int Med 2003, 254:31-40. Practical review of the mode of action of medications used for sarcoidosis taking a basic science standpoint.
8. Tahan V, Ozseker F, Guneylioglu D, et al.: Sarcoidosis after use of interferon for chronic hepatitis C. Dig Dis Sci 2003, 48:169-173.
9. Barnard J, Newman LS: Sarcoidosis: immunology, rheumatic involvement and therapeutics. Curr Opin Rheumatol 2001, 13:84-91.
10. Mathur A, Kremer JM: Immunopathology, rheumatic features and therapy of sarcoidosis. Curr Opin Rheumatol 1992, 4:76-80.
11. Gonzalez AA, Segura AM, Horiba K, et al.: Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study. Hum Pathol 2002, 33:1158-1164.
12. Ukae S, Tsutsumi H, Adachi N, et al.: Preschool sarcoidosis manifesting as juvenile rheumatoid arthritis: a case report and review of the literature of Japanese cases. Acta Paediatr Jpn 1994, 36:515-518.
13. Fink CW, Cimaz R: Early onset sarcoidosis: not a benign disease. J Rheumatol 1997, 24:174-177.
14. Schlaegel TF Jr.: Uveitis and miscellaneous general disease. Int Ophthalmol Clin 1977, 17:195-206.
15. Warshauer DM, Dumbleton SA, Molina PL, et al.: Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology 1994, 192:93-98.
16. Warshauer DM, Molina PL, Hamman SM, et al.: Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 1995, 195:757-762.
17. Xiao GQ, Zinberg JM, Unger PD: Asymptomatic sarcoidosis presenting as massive splenomegaly. Am J Med 2002, 113:698-699.
18. Lidar M, Langevitz P, Livneh A et al. Sclerosing cholangitis associated with systemic sarcoidosis. J Clin Gastroenterol 2003, 36:84-85.
19. Layden TJ, Kulik L: Hepatic manifestations of pulmonary diseases. Clin Liver Dis 2002, 6:969-979.
20. Reynolds HY: Sarcoidosis: impact of other illnesses on the presentation and management of multiorgan disease. Lung 2002, 180:281-299.
21. Ripudaman SB, Cummings OW, Cho WK: Symptomatic gastrointestinal sarcoidosis; case report and review of the literature. Dig Dis Sci 2003, 48:174-178.
22. Ishimaru K, Isomoto I, Okimoto T, et al.: Sarcoidosis of the breast. Eur Radiol 2002, 12:S105-S108.
23. Lieberman J: Elevation of serum angiotensin converting enzyme (ACE) level in sarcoidosis. Am J Med 1975, 59:365-372.
24. Costabel U, Teschler H: Biochemical changes in sarcoidosis. Clin Chest Med 1997, 18:827-842.
25. Alavi A, Gupta N, Alberini JL, et al.: Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002, 22:293-321. Very interesting article describing the use of new positron emission tomography techniques in cases where the diagnosis of thoracic disorders is difficult with conventional diagnostic methods.
26. Vignaux O, Dhote R, Duboc D, et al.: Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. Chest 2002, 122:1895-1901.
27. Pettersson T: Rheumatic features of sarcoidosis. Curr Opin Rheumatol 1998, 10:73-78.
28. Perruquet JL, Harrington TM, Davis DE, et al.: Sarcoid arthritis in a North American Caucasian population. J Rheumatol 1984, 11:521-525.
29. Gran JT, Bøhmer E: Acute sarcoid arthritis: a favourable outcome? Scand J Rheumatol 1996, 25:70-73.
30. Kellner H, Späthling S, Herzer P: Ultrasoud findings in Lofgren's syndrome: is ankle swelling caused by arthritis, tenosynovitis or periarthritis. J Rheumatol 1992, 19:38-40.
31. Maña J, Gomez-Vaquero C, Salazar A, et al.: Periarticular ankle sarcoidosis: a variant of Lofgren's syndrome. J Rheumatol 1996, 23:874-877.
32. Maña J, Gomez-Vaquero C, Montero A, et al.: Lofgren's sindrome revisited: a study of 186 patients. Am J Med 1999, 107:240-245.
33. Jamal MM, Cilursu AM, Hoffman EL: Sarcoidosis presenting as acute myositis. Report and review of the literature. J Rheumatol 1988, 15:1868-1871.
34. Fujimoto H, Ikeda M, Shimofusa R, et al.: Sarcoidosis breaking the fascia and mimicking sarcoma. Skeletal Radiol 2002, 31:706-708.
35. Drosos AA, Constantopoulos SH, Psychos D, et al.: The forgotten cause of sicca complex; sarcoidosis. J Rheumatol 1998, 16:1548-1551.
36. Marx RE, Hartman KS, Rethman KV: A prospective study comparing incisional labial to incisional parotid biopsies in the detection and confirmation of sarcoidosis, Sjogren's disease, sialosis and lymphoma. J Rheumatol 1988, 15:621-629.
37. Fernandes SRM, Singsen BH, Hoffman GS: Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum 2000, 30:33-46.
38. Baughman RP, Sharma OP, Lynch JP III: Sarcoidosis: is therapy effective? Semin Respir Infect 1998, 13:255-273.
39. Baughman RP, Lynch JP: Difficult treatment issues in sarcoidosis. J Int Med 2003, 253:41-45. This paper reviews several agents that have been used for the treatment of sarcoidosis.
40. Wallace DJ: The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review. Lupus 1996, 5(suppl 1): S59-S64.
41. Katz J, Bruno MK, Winterkorn JMS, et al.: The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximab. Arch Neurol 2003, 60:426-430.
42. Baughman RP, Lower EE: Infliximab for refractory sarcoidosis. Sarc Vasc Diff Lung Dis 2001, 18:310.
43. Mallbris L, Ljunberg A, Hedblad MA, et al.: Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol 2003, 48:290-293.
44. Pettersen JA, Zochodne DW, Bell RB, et al.: Refractory neurosarcoidosis responding to infliximab. Neurology 2002, 59:1660-1661.
45. Yee A, Pochapin MB: Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001, 135:27-31.